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STAT3 is a transcriptional regulator that plays an important role in coordinating inflammation and immunity. In addition, there is
a growing appreciation of the role STAT3 signaling plays in response to organ injury following diverse insults. Acute kidney injury
(AKI) from ischemia-reperfusion injury is a common clinical entity with devastating consequences, and the recognition that
endothelial alterations contribute to kidney dysfunction in this setting is of growing interest. Consequently, we used a mouse
with a genetic deletion of Stat3 restricted to the endothelium to examine the role of STAT3 signaling in the pathophysiology of
ischemic AKI. In a mouse model of ischemic AKI, the loss of endothelial STAT3 signaling significantly exacerbated kidney
dysfunction, morphologic injury, and proximal tubular oxidative stress. The increased severity of ischemic AKI was associated
with more robust endothelial-leukocyte adhesion and increased tissue accumulation of F4/80+ macrophages. Moreover,
important proximal tubular adaptive mechanisms to injury were diminished in association with decreased tissue mRNA levels
of the epithelial cell survival cytokine IL-22. In aggregate, these findings suggest that the endothelial STAT3 signaling plays an
important role in limiting kidney dysfunction in ischemic AKI and that selective pharmacologic activation of endothelial STAT3
signaling could serve as a potential therapeutic target.
1. Introduction
Acute kidney injury (AKI) is a costly clinical entity associated
with significant morbidity and mortality [1–3]. Ischemia-
reperfusion injury (IRI) is one of the most common contrib-
utors to the development of AKI in a variety of clinical
scenarios and is a primary factor promoting the onset of
delayed graft function following transplantation [4–6]. The
pathophysiology of ischemic AKI involves a complex inter-
play between epithelial tubular injury, inflammation, and
microvascular dysfunction that culminates in a decrement
of glomerular filtration rate (GFR) that is the ultimate com-
mon denominator of AKI [7]. Acute alterations in the kidney
microvascular endothelium have been observed in animal
models of AKI [8–11], and these alterations confer a variety
of functional consequences that can contribute to diminished
GFR. The endothelial cells of the peritubular microcircula-
tion play a key role in the regulation of many important
vascular functions including blood flow rates, blood coagula-
tion and fibrinolysis, leukocyte attachment, and the transca-
pillary passage of cells and different molecules from the
blood into the interstitium. Endothelial cells are located in
close proximity to other cell types in the kidney and thus
are keenly positioned to be in constant dialog not only with
circulating cells in the blood but with adjacent smooth mus-
cle cells, pericytes, tissue-resident leukocytes, and tubular
epithelial cells. Furthermore, there is an emerging apprecia-
tion that cross-talk signaling to the endothelium is necessary
for the maintenance of microvascular structure in the kidney
[12–14]. However, little is known about the mechanisms that
lead to alterations of microvascular endothelial function in
the setting of ischemic AKI.
The signal transducer and activator of transcription
(STAT) family of proteins is the principal signal transducers
for many cytokines and growth factors in mammalian cells,
and it plays an important regulatory role in the cellular
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response to acute stress such as occurs in IRI [15]. The STAT
family of proteins is comprised of at least seven different
members in mammals, and as the name implies, they are
important for signal transduction following receptor-
mediated events through the activation of transcription.
STAT3 is distinctive among the STAT family of proteins in
the embryonic lethality of its genetic loss, the diverse spec-
trum of signaling molecules that activate it, and the variabil-
ity in transcription networks it activates from one cell type to
another [16–20]. In addition, STAT3 is also known to have
important nontranscriptional regulatory functions [21–23].
Studies utilizing strategies to directly modulate STAT3
have demonstrated that STAT3 activation protects the
proximal tubular cell by limiting apoptosis in cell culture
models of ischemic AKI [24] and in animal models of
both nephrotoxic injury [25] and ischemic AKI [26]. Fur-
thermore, studies have demonstrated that STAT3 signaling
in kidney proximal tubule cells stimulated by the epithelial
cell survival cytokine interleukin-22 (IL-22), a member of
the IL-10 family of cytokines, is protective in an animal
model of ischemic AKI [27, 28]. However, recent work has
implicated STAT3 activation in tubular epithelial cells with
the progression of kidney interstitial fibrosis [29]. Accord-
ingly, the outcome of STAT3 activation may be dependent
on timing, the context of the stimulant, and the cell in which
it is activated. While the above studies begin to shed light on
our understanding of STAT3 function in tubular epithelial
cells during acute stress, essentially nothing is known about
the function of STAT3 in kidney microvascular endothelial
cells in response to stress. However, studies in cardiac IRI
[30], endotoxin-induced liver injury [31], and hyperoxic lung
injury [32] support the concept that endothelial STAT3 acti-
vation initiates important protective responses. Interestingly,
recent work has demonstrated that JAK/STAT signaling
pathways are highly upregulated in the microvascular endo-
thelium during ischemic AKI as determined by cell-specific
translational profiling [33].
In this study, we utilize a mouse with a selective genetic
deletion of Stat3 in endothelial cells to examine the effect of
endothelial STAT3 signaling on injury in a model of ischemic
AKI. We demonstrate that the selective loss of endothelial
STAT3 signaling enhances tubular cell injury as well as the
inflammatory response following IRI in the kidney. These
findings suggest that targeting activation of STAT3 in the
kidney microvascular endothelium during ischemic injury
may serve as an important therapeutic intervention to miti-
gate ischemic AKI.
2. Materials and Methods
2.1. Animals and Experimental Models. All animal protocols
were approved by the Indiana University Institutional Ani-
mal Care Committee and conform to the NIH Guide for
the Care and Use of Laboratory Animals. Mice on a
C57BL/6 background with a genetic deletion of Stat3
restricted to the endothelium (eStat3−/−) were obtained as a
kind gift from Dr. Xin-Yuan Fu [31]. C57BL/6 mice (WT)
were obtained from Jackson Laboratory (Bar Harbor, Maine)
and used as the background control. Ischemic AKI was
induced using a bilateral renal artery clamp (BAC) model
in C57BL/6 and eStat3−/− male mice weighing 20–30 grams
as previously described [34]. Sham surgery consisted of an
identical procedure without placement of the microserrifine
clamps to the renal arteries. For indicated experiments
involving intravital imaging, Escherichia coli serotype
0128:B12 endotoxin (Sigma-Aldrich, St. Louis, MO) was
given intraperitoneally (5mg/kg) four hours before imaging
as previously described [35]. Kidneys were harvested at the
time of sacrifice and subsequently processed for further stud-
ies as described elsewhere in this section. Measurement of
serum creatinine concentrations was performed at the UT
Southwestern O’Brien Kidney Research Core Center.
2.2. Histopathology, Immunostaining, Immunoblotting, and
Tissue Imaging. At the time of sacrifice, kidneys were rapidly
perfusedly fixed with 4% paraformaldehyde. Tissues were
subsequently processed for immunostaining or standard his-
tochemistry. Primary antibodies to hemeoxygenase-1 (rabbit
polyclonal IgG, ADI-SPA-895, Enzo Life Sciences, Farming-
dale, NY), phospho-STAT3 (Tyr705, rabbit monoclonal IgG,
D3A7; Cell Signaling Technology, Danvers, MA), and F4/80
(Clone CI:A3-1; Bio-Rad/AbD Serotec, Hercules, CA) were
utilized for immunostaining. Appropriate secondary anti-
bodies conjugated with Texas Red or horseradish peroxidase
(HRP) were purchased from Jackson ImmunoResearch Lab-
oratories, West Grove, PA. Negative controls were obtained
by incubating kidney tissue sections from sham animals
and animals undergoing renal ischemia with secondary anti-
bodies in the absence of primary antibodies. Immunoblotting
for HO-1 was performed using the above primary antibody as
previously described [36]. Hematoxylin and eosin (H&E)
staining of kidney tissues was performed by the Indiana Uni-
versity Histopathology Lab utilizing standard histochemistry
procedures. Confocal immunofluorescent images of kidney
tissue sections were collected at ×60 magnification using a
LSM-510 Zeiss confocal microscope (Peabody, MA) or
Olympus FV1000 confocal microscope (Center Valley, PA).
H&E-stained images and HRP-stained images of kidney tis-
sue sections were obtained at ×10 and ×40 magnification,
respectively, with a Nikon Microphot-SA equipped with a
SPOT RT Slider camera (Diagnostic Instruments Inc.,
Melville, NY). H&E sections were scored for tubular injury
as previously described [37]. Percent of total area staining
positive for HO-1 in each image was determined with Meta-
morph software (Universal Imaging, West Chester, PA).
Tubular epithelial cells with nuclei staining positive for
phospho-STAT3 and nucleated interstitial cells with staining
positive for F4/80 in each field were manually counted.
Tissue scoring and tissue cell counts were quantified by a
blinded individual. Five to seven images of the kidney were
collected from each animal.
2.3. Multiphoton Intravital Imaging of the Kidney. Anesthe-
tized animals were placed on the microscope stage with the
exposed intact kidney placed in a coverslip-bottomed cell
culture dish bathed in warmed (37°C) isotonic saline, as
previously described [38, 39]. Live animal imaging was
performed using an Olympus FV1000-MPE confocal/
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multiphoton scanner. The scanner is equipped with a Spectra
Physics Mai Tai DeepSee laser and 12-bit gallium arse-
nide detectors. For experiments examining kidney oxida-
tive stress, carboxy-2′,7′-dichlorodihydrofluorescein diacetate
(carboxy-DCFDA; Thermo Fisher Scientific/Invitrogen,
Carlsbad, CA) was administered intravenously (7mg/kg)
20 minutes prior to intravital imaging as previously described
[35]. For experiments examining leukocyte adhesion, a
fluorescein isothiocyanate- (FITC-) conjugated dextran
(500 kDa; TDB Consultancy AB, Uppsala, Sweden) was
injected intravenously at the time of intravital imaging to
define the vascular space as previously described [39], and
leukocyte adhesion to the microvascular endothelium was
analyzed as previously described [40]. Quantitative analysis
of acquired images was performed withMetamorph software.
2.4. Real-Time Quantitative PCR. RNA was extracted
from snap-frozen kidneys using TRIzol. Reverse tran-
scription on approximately 8μg of RNA was performed
using the High-Capacity cDNA Reverse Transcription Kit
(Life Technologies). IL-22 (Mm00444241_m1) and IL-10
(Mm004369614_m1) Applied Biosystems TaqMan gene
expression assays were used. Real-time quantitative PCR
amplifications were performed for 40 cycles using the 7500
Real-Time PCR Systems (Life Technologies). The ΔΔCt
method was used to analyze the relative changes in gene
expression. Endogenous glyceraldehyde-3-phosphate dehy-
drogenase (GAPDH) expression was used as a control to
normalize data.
2.5. Statistical Analysis. Data were analyzed for statistical
significance using ANOVA and pairwise t-tests or a nested
ANOVA for nested data within the study animal. Data are
reported as means with SD. Significance was set at P < 0 05.
3. Results and Discussion
3.1. Genetic Deletion of Endothelial Cell Stat3 Exacerbates
Ischemic AKI. Following induction of ischemic AKI by
bilateral renal artery clamp (BAC), eStat3−/− mice demon-
strated a significantly greater increase in serum creatinine.
Mean serum creatinine 24 hours after a 19-minute BAC was
3.0 + 0.2mg/dL in the eStat3−/− mice as compared to 1.2 +
0.9mg/dL in the background C57BL/6 mice (Figure 1(a)).
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Figure 1: Serum creatinine 24 hours after BAC or sham surgery is depicted in (a). P < 0 05 compared to sham (∗) or control ischemia (+).
Representative H&E images of the outer medulla 24 hours after BAC are shown in (b). Note the increased cast formation and necrosis in
the eStat3−/− mice.
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Figure 2: eStat3−/− and control mice were administered LPS
(5mg/kg i.p.) 4 hours prior to imaging and carboxy-DCFDA
20 minutes prior to imaging to assess tubular oxidative stress.
(a) Representative images of carboxy-DCFDA fluorescence under
the conditions as labeled. (b) The quantitative mean fluorescence
for each condition (n = 3). Oxidative stress is significantly in
greater degree in the eStat3−/− mice following LPS administration
as compared to control mice receiving LPS (∗+P < 0 05) or vehicle
control (∗P < 0 05).
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Histologic damage was also significantly greater in the
eStat3−/− mice as compared to the background C57BL/6
mice with mean tubular damage scores of 3.7 + 5 in the
eStat3−/− mice and 2.3 + 0.9 in the background C57BL/6
mice (Figure 1(b), P < 0 05) as defined by Kelly and
coworkers [37].
3.2. Proximal Tubule Oxidative Stress Is Increased in eStat3−/−
Mice during AKI. Oxidative stress is a prominent patho-
physiologic mechanism contributing to organ dysfunction
in all types of acute kidney injury including ischemic
AKI [41]. To ascertain the effect of the genetic deletion
of Stat3 in endothelial cells on kidney oxidative stress
during injury, we utilized intravital multiphoton micros-
copy and carboxy-DCFDA, which is an intracellular-
retained fluorescent indicator of reactive oxygen species.
This can be used to visualize oxidative stress in the most
vulnerable segment of the tubule, the proximal tubule
[41], of the mouse kidney following injection of lipopoly-
saccharide (LPS) as previously described [35]. We chose
to use an LPS model of AKI over the BAC model of
ischemic AKI for this investigation because it provided a
more consistent timing of oxidative stress for intravital
imaging. Figure 2 demonstrates that oxidative stress is
significantly higher in the proximal tubules of eStat3−/−
mice as compared to C57BL/6 mice following LPS injec-
tion thus providing evidence that endothelial STAT3
modulates oxidative stress in the kidney, specifically the
proximal tubule, during AKI.
3.3. Endothelial Cell Stat3 Deletion Increases Leukocyte
Endothelial Cell Interactions in the Kidney during AKI and
Increases Macrophage Accumulation in the Kidney during
AKI. Inflammatory responses play an important role in
injury, including the promotion of oxidative stress, during
ischemic AKI. Furthermore, the microvascular endothelium
serves as an important coordinator of inflammatory
responses during AKI [37, 42, 43] as the endothelial cell
can secrete a variety of cytokines and chemokines that can
activate, alert, and aim circulating inflammatory cells to
injury during IRI [44–48]. Several in vivo studies have dem-
onstrated the importance of endothelial STAT3 signaling in
regulating inflammatory responses. Exaggerated proinflam-
matory cytokine production has been demonstrated in
mouse models of cardiac IRI [30], endotoxin challenge [31],
and alcoholic liver injury [49] lacking endothelial STAT3.
Consequently, we next examined the impact of the endo-
thelial Stat3 deletion on microvascular leukocyte trafficking
and tissue leukocyte composition in our models of AKI.
Leukocyte adherence to the microvascular endothelium
was measured using intravital microscopy by a method
previously described [39, 40]. Figure 3(a) demonstrates
the quantification of leukocytes rolling or adherent to the
kidney microvascular endothelium during a three-minute
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Figure 3: Representative intravital image of adherent or rolling leukocytes (left; courtesy of Ruben Sandoval and Dr. Bruce A. Molitoris)
and quantification of adherent or rolling cells observed by intravital microscopy (right) following ischemic injury are shown in (a).
Representative images of F4/80 staining following ischemic injury are shown in (b). Arrows indicate F4/80-positive cells in the
interstitium representing macrophages. Average macrophage count per field is shown in (c). ∗P < 0 05.
4 Journal of Immunology Research
observation period per field. Leukocytes, likely neutrophils,
adherent to or rolling along the vascular endothelium of the
kidney in eStat3−/−mice were significantly increased as com-
pared to those in control mice following ischemic injury.
Histologic examination of tissue-resident leukocytes dem-
onstrates that the accumulation F4/80+ macrophages 24
hours after ischemic injury is significantly greater in
eStat3−/− mice than in control mice (Figures 3(b) and
3(c)). No difference in macrophage accumulation between
eStat3−/− and control mice was observed following sham
operation (data not shown). This finding is consistent
with prior studies demonstrating increased accumulation
of macrophages in mice lacking endothelial STAT3 during
alcohol liver injury [49]. We did not see a difference in
tissue neutrophils between eStat3−/− and control mice in
sham or ischemic AKI as assessed by leukocyte esterase
staining (data not shown).
3.4. The Heme Oxygenase-1 (HO-1) Response in Proximal
Tubules during AKI Is Reduced in eStat3−/− Mice. Heme
oxygenase-1 (HO-1) is a key mediator of protective adapta-
tions in the proximal tubule exposed to oxidative stress
[50], and the beneficial effects are thought to arise from the
degradation of prooxidant heme pigments released during
injury, the production of antioxidant bile pigments, and the
generation of carbon monoxide which has both salutary
vasoactive and anti-inflammatory properties. Because
expression of HO-1 is a key adaptive response for a variety
of acute insults to the proximal tubule, we sought to examine
the effect of the genetic deletion of Stat3 in endothelial cells
on the expression of HO-1 in the proximal tubule as a possi-
ble mechanistic link between enhanced proximal tubular
injury/oxidative stress and the genetic deletion of Stat3 in
endothelial cells in AKI. Figure 4 demonstrates that proximal
tubular HO-1 expression is diminished in the eStat3−/− mice
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Figure 4: Representative images of HO-1 immunostaining (red; actin = green) in animals 24 hours after BAC are shown in (a).
Immunostained images were analyzed to determine the percent area over threshold staining positive for HO-1 which is depicted in (b)
relative to sham control. (c) Representative immunoblots of cortical tissue for HO-1 24 hours after BAC (HO=HO-1; HS = histone for
loading control; I = ischemia; S = sham). Immunoblots were quantified by densitometry and expressed as average density normalized to
histone staining and relative to sham control. ∗P < 0 05.
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as compared to the C57BL/6 mice following ischemic injury.
These data suggest that endothelial STAT3 signaling is con-
nected to the downstream generation of adaptive proximal
tubular responses following injury.
3.5. The IL-22 mRNA Response in the Kidney Is Reduced and
IL-22 Signaling in the Proximal Tubule Is Diminished in
eStat3−/−Mice during Ischemic AKI. IL-22 is an epithelial cell
survival cytokine that belongs to the IL-10 family of cyto-
kines. IL-22 initiates signaling by binding to the heterodimer
IL-10R2/IL-22R1 receptor. IL-10R2 is ubiquitously expressed
whereas IL-22R1 is primarily expressed in epithelial cells of
the kidney (including proximal tubule), liver, gastrointestinal
tract, respiratory tract, and skin; however, it is notably absent
from cells of hematopoietic origin [51]. As mentioned
previously, IL-22 has been shown to be an important pro-
tective cytokine in ischemic AKI [28]. In addition, IL-22
induction of HO-1 through activation of STAT3 signaling
in the proximal tubular epithelial cell is partially responsi-
ble for this protective response [52]. Furthermore, a subset
of tissue-resident mononuclear phagocytes, including a
subset of F4/80+ cells, has been demonstrated to be an
important source of IL-22 during ischemic AKI [27]. Conse-
quently, IL-22 may serve as an important mediator linking
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Figure 5: Kidney tissues harvested from eStat3−/− and control mice 24 hours after ischemic injury were processed to examine IL-22 by RT-
PCR (a) and phospho (Y705)-tyrosine STAT3 (pSTAT) immunostaining as a measure of proximal tubule STAT3 activation (b, c). IL-22 gene
expression (a) was normalized to GAP6DH expression and then normalized to expression in sham control. Representative images of proximal
tubule pSTAT immunostaining are shown in (b). The total number of pSTAT-positive nuclei in proximal tubular cells was counted and
expressed a percent of total proximal tubular cell nuclei per field (graph). ∗P < 0 05.
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endothelial STAT3 regulation of the inflammatory response
to proximal tubule injury in ischemic AKI. Figure 5(a) dem-
onstrates that kidney IL-22 mRNA expression in AKI is
blunted in eStat3−/−mice as compared to background control
(C57BL/6) mice. Figures 5(b) and 5(c) demonstrate that acti-
vation of proximal tubular STAT3 signaling, as measured by
nuclear phosphor (Y705)-tyrosine STAT3 (pSTAT), is signif-
icantly reduced in eStat3−/− mice as compared to C57BL/6
mice. These data further suggest that in ischemic AKI, endo-
thelial STAT3 regulates resident leukocyte trafficking and
tissue-resident mononuclear phagocyte phenotype that in
turn alters adaptive mechanisms in the proximal tubule
through IL-22-mediated signaling.
4. Conclusions
Our findings demonstrate that loss of endothelial STAT3
signaling exacerbates injury in this rodent model of ischemic
AKI. Therefore, endothelial STAT3 signaling has a protective
role in ischemia-reperfusion injury of the kidney. This find-
ing is consistent with that of the previous work done in
various other models of organ injury [30–32]. As anticipated
with this model of AKI, heightened tubular injury and
interstitial inflammation were the predominant pathologic
alterations observed. No histopathologic differences in glo-
meruli were noted in this study which would suggest that
the endothelial STAT3 deletion differentially impacts peri-
tubular capillaries more so than glomerular capillaries in this
model, albeit more detailed studies of glomerular function
would need to be performed to further characterize the
consequences of the endothelial STAT3 deletion on glomer-
ular function during injury. Our observations suggest that
endothelial cell STAT3 signaling limits the trafficking of leu-
kocytes that have the potential to exacerbate ischemic injury
during AKI. Modulation of endothelial cytokine production,
regulation of endothelial cytokine response, and alteration of
endothelial adhesion molecule expression may all contribute
to this observation and provide another fruitful avenue of
future investigation. In addition, our observation that there
is an increase in tissue F4/80+ macrophages but a decrease
in IL-22 mRNA suggests that the infiltration is predomi-
nated by injurious M1 macrophages and not the reparative
M2 macrophages; thus, further investigation of the pheno-
typic distribution of the infiltrating F4/80 macrophages is
another potentially interesting path of future investigation.
Together, our findings in general underscore the complex
nature of the interplay between tubular injury, inflammation,
and endothelial alterations that comprise the pathophysiol-
ogy of AKI and identify endothelial STAT3 as a potential
regulator of this interplay. In particular, our findings suggest
that endothelial STAT3 may coordinate both tubular epithe-
lial cell adaptive mechanisms and inflammatory responses
that could independently impact kidney injury following
an ischemic insult. Furthermore, our findings suggest that
activation of endothelial STAT3 may have important
implications in the therapeutic approach to AKI; however,
it is also evident that timing, degree of activation, and cell-
specific targeting are additional hurdles that need to be
clarified in future studies [29, 53–58].
Conflicts of Interest
All authors declare that they have no conflicts of interest,
financial or otherwise.
Acknowledgments
Research reported in this publication was supported by a
Research Support Fund grant from Indiana University-
Purdue University Indianapolis to Timothy A. Sutton, the
National Institutes of Health (R01DK099345) to Timothy
A. Sutton and Pierre C. Dagher, and the National Institute
of Diabetes and Digestive and Kidney Diseases through the
Indiana O’Brien Center for Advanced Microscopic Analysis
(DK079312). The authors thank Dr. Xin-Yuan Fu and
Dr. Akira Moh for providing the eStat3−/− mice and for the
insightful discussions, as well as Ruben Sandoval and
Dr. Bruce A. Molitors for providing the representative
image in Figure 3(a).
References
[1] G. M. Chertow, E. Burdick, M. Honour, J. V. Bonventre, and
D. W. Bates, “Acute kidney injury, mortality, length of stay,
and costs in hospitalized patients,” Journal of the American
Society of Nephrology, vol. 16, no. 11, pp. 3365–3370, 2005.
[2] S. Uchino, J. A. Kellum, R. Bellomo et al., “Acute renal failure
in critically ill patients: a multinational, multicenter study,”
The Journal of the American Medical Association, vol. 294,
no. 7, pp. 813–818, 2005.
[3] A. Wonnacott, S. Meran, B. Amphlett, B. Talabani, and
A. Phillips, “Epidemiology and outcomes in community-
acquired versus hospital-acquired AKI,” Clinical Journal of
the American Society of Nephrology, vol. 9, no. 6, pp. 1007–
1014, 2014.
[4] F. Liano, J. Pascual, and Madrid acute renal failure study
group, “Epidemiology of acute renal failure: a prospective,
multicenter, community-based study,” Kidney International,
vol. 50, no. 3, pp. 811–818, 1996.
[5] R. L. Mehta, M. T. Pascual, S. Soroko et al., “Spectrum of
acute renal failure in the intensive care unit: the PICARD
experience,” Kidney International, vol. 66, no. 4, pp. 1613–
1621, 2004.
[6] N. Perico, D. Cattaneo, M. H. Sayegh, and G. Remuzzi,
“Delayed graft function in kidney transplantation,” Lancet,
vol. 364, no. 9447, pp. 1814–1827, 2004.
[7] J. V. Bonventre and L. Yang, “Cellular pathophysiology of
ischemic acute kidney injury,” The Journal of Clinical
Investigation, vol. 121, no. 11, pp. 4210–4221, 2011.
[8] S. V. Brodsky, T. Yamamoto, T. Tada et al., “Endothelial
dysfunction in ischemic acute renal failure: rescue by trans-
planted endothelial cells,” American Journal of Physiology -
Renal Physiology, vol. 282, no. 6, pp. F1140–F1149, 2002.
[9] J. Flores, D. R. DiBona, C. H. Beck, and A. Leaf, “The role of
cell swelling in ischemic renal damage and the protective effect
of hypertonic solute,” The Journal of Clinical Investigation,
vol. 51, no. 1, pp. 118–126, 1972.
[10] T. A. Sutton, H. E. Mang, S. B. Campos, R. M. Sandoval,
M. C. Yoder, and B. A. Molitoris, “Injury of the renal micro-
vascular endothelium alters barrier function after ischemia,”
7Journal of Immunology Research
American Journal of Physiology - Renal Physiology, vol. 285,
no. 2, pp. F191–F198, 2003.
[11] O. Kwon, C. L. Phillips, and B. A. Molitoris, “Ischemia induces
alterations in actin filaments in renal vascular smooth muscle
cells,” American Journal of Physiology - Renal Physiology,
vol. 282, no. 6, pp. F1012–F1019, 2002.
[12] B. S. Kim, J. Chen, T.Weinstein, E. Noiri, andM. S. Goligorsky,
“VEGF expression in hypoxia and hyperglycemia: reciprocal
effect on branching angiogenesis in epithelial-endothelial
co-cultures,” Journal of the American Society of Nephrology,
vol. 13, no. 8, pp. 2027–2036, 2002.
[13] C. Schrimpf, C. Xin, G. Campanholle et al., “Pericyte TIMP3
and ADAMTS1 modulate vascular stability after kidney
injury,” Journal of the American Society of Nephrology,
vol. 23, no. 5, pp. 868–883, 2012.
[14] D. P. Basile, K. Fredrich, B. Chelladurai, E. C. Leonard, and
A. R. Parrish, “Renal ischemia reperfusion inhibits VEGF
expression and induces ADAMTS-1, a novel VEGF inhibitor,”
American Journal of Physiology - Renal Physiology, vol. 294,
no. 4, pp. F928–F936, 2008.
[15] K. Boengler, D. Hilfiker-Kleiner, H. Drexler, G. Heusch, and R.
Schulz, “The myocardial JAK/STAT pathway: from protection
to failure,” Pharmacology & Therapeutics, vol. 120, no. 2,
pp. 172–185, 2008.
[16] E. J. Hillmer, H. Zhang, H. S. Li, and S. S. Watowich, “STAT3
signaling in immunity,” Cytokine & Growth Factor Reviews,
vol. 31, pp. 1–15, 2016.
[17] M. Szelag, A. Piaszyk-Borychowska, M. Plens-Galaska, J.
Wesoly, and H. A. Bluyssen, “Targeted inhibition of STATs
and IRFs as a potential treatment strategy in cardiovascular
disease,” Oncotarget, vol. 7, no. 30, pp. 48788–48812, 2016.
[18] K. Takeda, K. Noguchi, W. Shi et al., “Targeted disruption of
the mouse Stat3 gene leads to early embryonic lethality,”
Proceedings of the National Academy of Sciences of the United
States of America, vol. 94, no. 8, pp. 3801–3804, 1997.
[19] F. Vallania, D. Schiavone, S. Dewilde et al., “Genome-wide
discovery of functional transcription factor binding sites by
comparative genomics: the case of Stat3,” Proceedings of the
National Academy of Sciences of the United States of America,
vol. 106, no. 13, pp. 5117–5122, 2009.
[20] J. Yuan, F. Zhang, and R. Niu, “Multiple regulation pathways
and pivotal biological functions of STAT3 in cancer,” Scientific
Reports, vol. 5, article 17663, 2015.
[21] K. E. O'Sullivan, E. P. Breen, H. C. Gallagher, D. J. Buggy, and
J. P. Hurley, “Understanding STAT3 signaling in cardiac
ischemia,” Basic Research in Cardiology, vol. 111, no. 3, p. 27,
2016.
[22] J. Wegrzyn, R. Potla, Y. J. Chwae et al., “Function of mitochon-
drial Stat3 in cellular respiration,” Science, vol. 323, no. 5915,
pp. 793–797, 2009.
[23] R. Yang and M. Rincon, “Mitochondrial Stat3, the need for
design thinking,” International Journal of Biological Sciences,
vol. 12, no. 5, pp. 532–544, 2016.
[24] J. Wang, C. Ouyang, X. Chen, B. Fu, Y. Lu, and Q. Hong,
“STAT3 inhibits apoptosis of human renal tubular epithelial
cells induced by ATP depletion/recovery,” Nephron Experi-
mental Nephrology, vol. 108, no. 1, pp. e11–e18, 2008.
[25] L. Zhou, P. Fu, X. R. Huang, F. Liu, K. N. Lai, and H. Y. Lan,
“Activation of p53 promotes renal injury in acute aristolochic
acid nephropathy,” Journal of the American Society of Nephrol-
ogy, vol. 21, no. 1, pp. 31–41, 2010.
[26] J. Chen, J. K. Chen, E. M. Conway, and R. C. Harris, “Survivin
mediates renal proximal tubule recovery from AKI,” Journal
of the American Society of Nephrology, vol. 24, no. 12,
pp. 2023–2033, 2013.
[27] O. P. Kulkarni, I. Hartter, S. R. Mulay et al., “Toll-like receptor
4-induced IL-22 accelerates kidney regeneration,” Journal
of the American Society of Nephrology, vol. 25, no. 5,
pp. 978–989, 2014.
[28] M. J. Xu, D. Feng, H. Wang, Y. Guan, X. Yan, and B. Gao,
“IL-22 ameliorates renal ischemia-reperfusion injury by tar-
geting proximal tubule epithelium,” Journal of the American
Society of Nephrology, vol. 25, no. 5, pp. 967–977, 2014.
[29] F. Bienaimé, M. Muorah, L. Yammine et al., “Stat3 controls
tubulointerstitial communication during CKD,” Journal of
the American Society of Nephrology, vol. 27, no. 12, pp. 3690–
3705, 2016.
[30] M.Wang, W. Zhang, P. Crisostomo et al., “Endothelial STAT3
plays a critical role in generalized myocardial proinflammatory
and proapoptotic signaling,” American Journal of Physiology -
Heart and Circulatory Physiology, vol. 293, no. 4, pp. H2101–
H2108, 2007.
[31] A. Kano, M. J. Wolfgang, Q. Gao et al., “Endothelial cells
require STAT3 for protection against endotoxin-induced
inflammation,” The Journal of Experimental Medicine,
vol. 198, no. 10, pp. 1517–1525, 2003.
[32] X. Zhang, P. Shan, G. Jiang et al., “Endothelial STAT3 is
essential for the protective effects of HO-1 in oxidant-
induced lung injury,” The FASEB Journal, vol. 20, no. 12,
pp. 2156–2158, 2006.
[33] J. Liu, A. M. Krautzberger, S. H. Sui et al., “Cell-specific
translational profiling in acute kidney injury,” The Journal
of Clinical Investigation, vol. 124, no. 3, pp. 1242–1254,
2014.
[34] P. C. Dagher, T. Hato, H. E. Mang et al., “Inhibition of toll-like
receptor 4 signaling mitigates microvascular loss but not
fibrosis in a model of ischemic acute kidney injury,” Interna-
tional Journal of Molecular Sciences, vol. 17, no. 5, 2016.
[35] R. Kalakeche, T. Hato, G. Rhodes et al., “Endotoxin uptake by
S1 proximal tubular segment causes oxidative stress in the
downstream S2 segment,” Journal of the American Society of
Nephrology, vol. 22, no. 8, pp. 1505–1516, 2011.
[36] S. Y. Lee, M. Horbelt, H. E. Mang et al., “MMP-9 gene deletion
mitigates microvascular loss in a model of ischemic acute kid-
ney injury,” American Journal of Physiology - Renal Physiology,
vol. 301, 2011.
[37] K. J. Kelly, W.W.Williams Jr., R. B. Colvin et al., “Intercellular
adhesion molecule-1-deficient mice are protected against
ischemic renal injury,” The Journal of Clinical Investigation,
vol. 97, no. 4, pp. 1056–1063, 1996.
[38] K. W. Dunn, R. M. Sandoval, K. J. Kelly et al., “Functional
studies of the kidney of living animals using multicolor two-
photon microscopy,” American Journal of Physiology - Cell
Physiology, vol. 283, no. 3, pp. C905–C916, 2002.
[39] K. W. Dunn, T. A. Sutton, and R. M. Sandoval, “Live-ani-
mal imaging of renal function by multiphoton microscopy,”
Current Protocols in Cytometry, vol. Chapter 14, 2012,
Unit12 19.
[40] A. A. Sharfuddin, R. M. Sandoval, D. T. Berg et al., “Soluble
thrombomodulin protects ischemic kidneys,” Journal of the
American Society of Nephrology, vol. 20, no. 3, pp. 524–
534, 2009.
8 Journal of Immunology Research
[41] D. P. Basile, M. D. Anderson, and T. A. Sutton, “Pathophysiol-
ogy of acute kidney injury,” Comprehensive Physiology, vol. 2,
no. 2, pp. 1303–1353, 2012.
[42] K. J. Kelly, W. W. Williams Jr., R. B. Colvin, and J. V.
Bonventre, “Antibody to intercellular adhesion molecule 1
protects the kidney against ischemic injury,” Proceedings of
the National Academy of Sciences of the United States of
America, vol. 91, no. 2, pp. 812–816, 1994.
[43] M. Takada, K. C. Nadeau, G. D. Shaw, K. A. Marquette,
and N. L. Tilney, “The cytokine-adhesion molecule cascade
in ischemia/reperfusion injury of the rat kidney. Inhibition
by a soluble P-selectin ligand,” The Journal of Clinical
Investigation, vol. 99, no. 11, pp. 2682–2690, 1997.
[44] P. Chen, M. Shibata, R. Zidovetzki, M. Fisher, B. V. Zlokovic,
and F. M. Hofman, “Endothelin-1 and monocyte chemoat-
tractant protein-1 modulation in ischemia and human
brain-derived endothelial cell cultures,” Journal of Neuroim-
munology, vol. 116, no. 1, pp. 62–73, 2001.
[45] N. G. Frangogiannis, G. Ren, O. Dewald et al., “Critical role of
endogenous thrombospondin-1 in preventing expansion of
healing myocardial infarcts,” Circulation, vol. 111, no. 22,
pp. 2935–2942, 2005.
[46] N. Jo, G. S. Wu, and N. A. Rao, “Upregulation of chemokine
expression in the retinal vasculature in ischemia-reperfusion
injury,” Investigative Ophthalmology & Visual Science, vol. 44,
no. 9, pp. 4054–4060, 2003.
[47] D. J. Oh, B. Dursun, Z. He et al., “Fractalkine receptor
(CX3CR1) inhibition is protective against ischemic acute renal
failure in mice,” American Journal of Physiology - Renal
Physiology, vol. 294, no. 1, pp. F264–F271, 2008.
[48] G. Tarozzo, M. Campanella, M. Ghiani, A. Bulfone, and
M. Beltramo, “Expression of fractalkine and its receptor,
CX3CR1, in response to ischaemia-reperfusion brain injury
in the rat,” The European Journal of Neuroscience, vol. 15,
no. 10, pp. 1663–1668, 2002.
[49] A. M. Miller, H. Wang, O. Park et al., “Anti-inflammatory and
anti-apoptotic roles of endothelial cell STAT3 in alcoholic liver
injury,” Alcoholism, Clinical and Experimental Research,
vol. 34, no. 4, pp. 719–725, 2010.
[50] K. A. Nath, G. Balla, G. M. Vercellotti et al., “Induction of
heme oxygenase is a rapid, protective response in rhabdomyol-
ysis in the rat,” The Journal of Clinical Investigation, vol. 90,
no. 1, pp. 267–270, 1992.
[51] E. Witte, K. Witte, K. Warszawska, R. Sabat, and K. Wolk,
“Interleukin-22: a cytokine produced by T, NK and NKT cell
subsets, with importance in the innate immune defense
and tissue protection,” Cytokine & Growth Factor Reviews,
vol. 21, no. 5, pp. 365–379, 2010.
[52] W. W. Xing, M. J. Zou, S. Liu et al., “Hepatoprotective effects
of IL-22 on fulminant hepatic failure induced by D-galactos-
amine and lipopolysaccharide in mice,” Cytokine, vol. 56,
no. 2, pp. 174–179, 2011.
[53] T. Arakawa, T. Masaki, T. Hirai et al., “Activation of signal
transducer and activator of transcription 3 correlates with cell
proliferation and renal injury in human glomerulonephritis,”
Nephrology, Dialysis, Transplantation, vol. 23, no. 11,
pp. 3418–3426, 2008.
[54] C. C. Berthier, H. Zhang, M. Schin et al., “Enhanced expression
of Janus kinase-signal transducer and activator of transcrip-
tion pathway members in human diabetic nephropathy,”
Diabetes, vol. 58, no. 2, pp. 469–477, 2009.
[55] X. Feng, T. C. Lu, P. Y. Chuang et al., “Reduction of Stat3
activity attenuates HIV-induced kidney injury,” Journal of
the American Society of Nephrology, vol. 20, no. 10, pp. 2138–
2146, 2009.
[56] M. Kuratsune, T. Masaki, T. Hirai et al., “Signal transducer and
activator of transcription 3 involvement in the development of
renal interstitial fibrosis after unilateral ureteral obstruction,”
Nephrology, vol. 12, no. 6, pp. 565–571, 2007.
[57] T. C. Lu, Z. H. Wang, X. Feng et al., “Knockdown of Stat3
activity in vivo prevents diabetic glomerulopathy,” Kidney
International, vol. 76, no. 1, pp. 63–71, 2009.
[58] G. Ortiz-Muñoz, V. Lopez-Parra, O. Lopez-Franco et al.,
“Suppressors of cytokine signaling abrogate diabetic nephrop-
athy,” Journal of the American Society of Nephrology, vol. 21,
no. 5, pp. 763–772, 2010.
9Journal of Immunology Research
